-
Personalized Outcome Assessment Using Goal Attainment Scaling
Oct 8, 2026, 14:19 PM -
Evolving HTA Systems in Latin America: Access & Innovation
Oct 7, 2026, 14:11 PM -
Endpoints That Matter: Integrating Patient-Relevant Outcomes in HTA
Oct 6, 2026, 15:03 PM -
Creating Defensible Evidence With External Control Arms
Sep 30, 2026, 17:11 PM -
Whole Health Evaluation of Multi-System Risk: GLP-1 Insights
Aug 13, 2026, 15:26 PM -
When Evidence Drives Adoption: How Investors Evaluate Diagnostic, Device, and MedTech Innovation in a Policy Constrained Market
Jul 30, 2026, 17:33 PM -
HEOR Career Development for New Professionals: Things I Wish I Knew
Jul 29, 2026, 19:21 PM -
ISPOR Top 10 HEOR Trends - What Are The Key Themes for 2026-27?
Jul 22, 2026, 13:24 PM -
Harnessing AI to Transform HEOR and Real‑World Evidence Generation in Rare Diseases: Regulatory Expectations, Opportunities, and Practical Use Cases
Jul 16, 2026, 16:12 PM -
Designing for Access: Early Integrated Evidence Generation Planning in the Era of Expanded Value Frameworks
Jun 30, 2026, 16:38 PM -
Beyond the Research Assistant: Innovative Uses of AI in Health Preference Research
Jun 25, 2026, 12:51 PM -
Understanding the First JCAs: Practical Takeaways for Key Stakeholders
Jun 23, 2026, 15:41 PM -
From Evidence to Access: Applying HEOR and Economic Evaluation in Healthcare Decision-Making
Jun 17, 2026, 13:16 PM -
Delphi or Not Delphi: Selecting the Appropriate Expert Elicitation Approach
Jun 16, 2026, 15:16 PM -
Healthcare Ecosystem-led Thinking: The Global Reset
Apr 15, 2026, 14:55 PM -
Defining Value Upstream: A Canadian Success Story in Early Modeling
Apr 1, 2026, 13:13 PM -
The Application of AI in COA Research: Opportunities and Challenges
Dec 3, 2025, 13:18 PM -
HEOR Meets Investing—Why Are Banks and VCs Collaborating With Health Economists?
Dec 2, 2025, 14:17 PM -
The Case for Integrated RWE Generation Across the Product Lifecycle
Oct 23, 2025, 10:23 AM -
How to Develop Compelling Session Proposals for ISPOR Conferences
Oct 15, 2025, 14:02 PM
